In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 ...

Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by maximizing the impact of existing research and making the most out of ...

Understanding how obesity has been portrayed in art across the ages can make doctors more empathic and less judgmental, which ...

Researchers have proposed new standards into the decades' old prosthetic donations market, improving the quality of lower ...

A study supported by FAPESP and published in the journal Scientific Reports showed a strong correlation between the ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

University of California, Irvine researchers have invented a wearable, wireless, battery-free, bioelectronic sensor to monitor users' health by analyzing molecular biomarkers in human sweat.

Gene editing can repair a DNA error in mice that causes Dravet syndrome, a rare, incurable, and potentially deadly form of ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the ...

Northwestern University engineers have developed a small, wireless polygraph system you can wear. Unlike polygraphs used in ...

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a ...

Giving tranexamic acid to women with placenta praevia (when the placenta covers the cervical opening) undergoing cesarean ...